LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 186 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,729,000 | -45.6% | 27,478 | +10.1% | 0.13% | -33.7% |
| Q3 2018 | $6,849,000 | +53.3% | 24,952 | +15.7% | 0.20% | +46.3% |
| Q2 2018 | $4,468,000 | +26.6% | 21,565 | +0.9% | 0.13% | +54.0% |
| Q1 2018 | $3,529,000 | +178.5% | 21,366 | +72.0% | 0.09% | +141.7% |
| Q3 2016 | $1,267,000 | -76.3% | 12,419 | -72.3% | 0.04% | -76.8% |
| Q2 2016 | $5,340,000 | +12.4% | 44,775 | +0.9% | 0.16% | +4.7% |
| Q1 2016 | $4,751,000 | +62.9% | 44,368 | +64.9% | 0.15% | +57.4% |
| Q4 2015 | $2,917,000 | +208.0% | 26,904 | +77.0% | 0.09% | +327.3% |
| Q2 2014 | $947,000 | -62.1% | 15,200 | -59.0% | 0.02% | -63.3% |
| Q1 2014 | $2,496,000 | +19.0% | 37,100 | -6.9% | 0.06% | +7.1% |
| Q4 2013 | $2,097,000 | +37.2% | 39,864 | +12.9% | 0.06% | +14.3% |
| Q3 2013 | $1,528,000 | – | 35,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |